DaVita (DVA) Research Brief — As of August 3, 2026

Overview

DaVita Inc. is a leading U.S. provider of kidney dialysis services, operating within a domestic duopoly and serving approximately 296,300 patients across 3,262 outpatient dialysis centers globally as of March 31, 2026 [17]. The company generates the vast majority of its revenue through per-treatment reimbursements from commercial insurers and government programs (Medicare/Medicaid), supplemented by its growing Integrated Kidney Care (IKC) segment [4].

---

Recent Catalysts (Last ~1–3 Months)